From: The role of oncostatin M receptor gene polymorphisms in bladder cancer
Characteristics | Cases No. (%) | Genotype No. (%) | P value | Allele No. (%) | P value | OR (95%CI) | |||
---|---|---|---|---|---|---|---|---|---|
GG | GA | AA | G | A | |||||
Gender | |||||||||
 Male | 241 (78.8) | 104 (43.1) | 110 (45.6) | 27 (11.2) | 0.62 | 318 (66.0) | 164 (34.0) | 0.84 | 1.04 (0.69–1.57) |
 Female | 65 (21.2) | 29 (44.6) | 29 (44.6) | 7 (10.8) | 87 (66.9) | 43 (33.1) | |||
Age | |||||||||
 ≤ 64 | 139 (45.4) | 61 (43.9) | 61 (43.9) | 17 (12.2) | 0.92 | 183 (65.8) | 95 (34.2) | 0.87 | 1.03 (0.74–1.44) |
 > 64 | 167 (54.6) | 72 (43.1) | 78 (46.7) | 17 (10.2) | 222 (66.5) | 112 (33.5) | |||
Smoking status | |||||||||
 Non-smokers | 147 (48.0) | 58 (39.5) | 69 (46.9) | 20 (13.6) | 0.16 | 185 (62.9) | 109 (37.1) | 0.1 | 1.32 (0.95–1.85) |
 Smokers | 159 (52.0) | 75 (47.2) | 70 (44.0) | 14 (8.8) | 220 (69.2) | 98 (30.8) | |||
Stage | |||||||||
 NMIBC | 164 (53.6) | 71 (43.3) | 73 (44.5) | 20 (12.2) | 0.80 | 215 (65.5) | 113 (34.5) | 0.97 | 1.00 (0.72–1.41) |
 MIBC | 142 (46.4) | 62 (43.7) | 66 (46.5) | 14 (9.9) | 190 (66.9) | 94 (33.1) | |||
Grade | |||||||||
 Low | 132 (43.1) | 57 (43.2) | 56 (42.4) | 19 (14.4) | 0.4 | 170 (64.3) | 94 (34.8) | 0.42 | 1.15 (0.82–1.61) |
 High | 174 (56.9) | 76 (43.7) | 83 (47.7) | 15 (8.6) | 235 (67.5) | 113 (32.5) | |||
Recurrence | |||||||||
 Negative | 217 (70.9) | 99 (45.9) | 94 (43.3) | 24 (11.1) | 0.54 | 292 (67.3) | 142 (32.7) | 0.37 | 0.85 (0.59–1.22) |
 Positive | 89 (29.1) | 34 (38.2) | 45 (50.6) | 10 (11.2) | 113 (63.5) | 65 (36.5) |